Follow
David R Matthews
David R Matthews
Professor of Diabetes, University of Oxford
Verified email at ocdem.ox.ac.uk
Title
Cited by
Cited by
Year
Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
DR Matthews, JP Hosker, AS Rudenski, BA Naylor, DF Treacher, ...
diabetologia 28, 412-419, 1985
373081985
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
UK Prospective Diabetes Study (UKPDS) Group
The lancet 352 (9131), 837-853, 1998
234201998
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton, AI Adler, HAW Neil, DR Matthews, SE Manley, CA Cull, ...
Bmj 321 (7258), 405-412, 2000
126962000
10-year follow-up of intensive glucose control in type 2 diabetes
RR Holman, SK Paul, MA Bethel, DR Matthews, HAW Neil
New England journal of medicine 359 (15), 1577-1589, 2008
99842008
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
UK Prospective Diabetes Study (UKPDS) Group
The Lancet 352 (9131), 854-865, 1998
92121998
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
UK Prospective Diabetes Study Group
Bmj 317 (7160), 703-713, 1998
91621998
Canagliflozin and cardiovascular and renal events in type 2 diabetes
B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ...
New England Journal of Medicine 377 (7), 644-657, 2017
76162017
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes Spectrum 25 (3), 154-171, 2012
7473*2012
Use and abuse of HOMA modeling
TM Wallace, JC Levy, DR Matthews
Diabetes care 27 (6), 1487-1495, 2004
59302004
Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European …
SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ...
Diabetes care 38 (1), 140-149, 2015
36042015
Publication bias in clinical research
PJ Easterbrook, R Gopalan, JA Berlin, DR Matthews
The Lancet 337 (8746), 867-872, 1991
35511991
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
AI Adler, IM Stratton, HAW Neil, JS Yudkin, DR Matthews, CA Cull, ...
Bmj 321 (7258), 412-419, 2000
31392000
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)
RC Turner, H Millns, HAW Neil, IM Stratton, SE Manley, DR Matthews, ...
Bmj 316 (7134), 823-828, 1998
29651998
Correct homeostasis model assessment (HOMA) evaluation uses the computer program
JC Levy, DR Matthews, MP Hermans
Diabetes care 21 (12), 2191, 1998
23081998
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
22242006
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
UK Prospective Diabetes Study Group
Bmj 317 (7160), 713-720, 1998
22201998
UK Prospective Diabetes Study 16: overview of 6 years' therapy of type II diabetes: a progressive disease
UK Prospective Diabetes Study Group
Diabetes 44 (11), 1249-1258, 1995
17731995
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in …
M Nauck, A Frid, K Hermansen, NS Shah, T Tankova, IH Mitha, ...
Diabetes care 32 (1), 84-90, 2009
15272009
UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis
IM Stratton, EM Kohner, SJ Aldington, RC Turner, RR Holman, SE Manley, ...
Diabetologia 44, 156-163, 2001
13192001
Psychosocial problems and barriers to improved diabetes management: results of the Cross‐National Diabetes Attitudes, Wishes and Needs (DAWN) Study
M Peyrot, RR Rubin, T Lauritzen, FJ Snoek, DR Matthews, SE Skovlund
Diabetic medicine 22 (10), 1379-1385, 2005
12172005
The system can't perform the operation now. Try again later.
Articles 1–20